Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Szer

Showing results (141-150 of 195) with videos related to

Pageof 20
Sort By:
Leukemia & Lymphoma|September 1, 1994
The influence of induction chemotherapy dose and dose intensity on the duration of remission in acute myeloid leukemia. Australian Leukemia Study GroupJ F Bishop, J P Matthews, G Young, et al.
Medical Mycology|January 30, 2017
Is a biomarker-based diagnostic strategy for invasive aspergillosis cost effective in high-risk haematology patients?N Macesic, C O Morrissey, D Liew, et al.
Blood|August 1, 1991
Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2E A Copelan, J C Biggs, J M Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
Radiation-free preparation for allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemiaE A Copelan, J C Biggs, B R Avalos, et al.
Transplantation Proceedings|March 27, 2001
Clinical relevance of the minor histocompatibility antigen HA-1 in allogeneic bone marrow transplantation between HLA identical siblingsB D Tait, R Maddison, J McCluskey, et al.
Bone Marrow Transplantation|July 30, 2013
Towards a global system of vigilance and surveillance in unrelated donors of haematopoietic progenitor cells for transplantationB E Shaw, J Chapman, M Fechter, et al.
Bone Marrow Transplantation|January 1, 1993
Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapyA Grigg, C G Begley, C A Juttner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1995
Adjuvant treatment of high-risk breast cancer using multicycle high-dose chemotherapy and filgrastim-mobilized peripheral blood progenitor cellsR L Basser, L B To, C G Begley, et al.
Bone Marrow Transplantation|July 1, 1994
Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignanciesW P Sheridan, C G Begley, L B To, et al.
Internal Medicine Journal|December 9, 2014
Survey of antifungal prophylaxis and fungal diagnostic tests employed in malignant haematology and haemopoietic stem cell transplantation (HSCT) in Australia and New ZealandS J van Hal, N M Gilroy, C O Morrissey, et al.
Pageof 20

Showing results (141-150 of 195) with videos related to

Sort By:
Pageof 20
Leukemia & Lymphoma|September 1, 1994
The influence of induction chemotherapy dose and dose intensity on the duration of remission in acute myeloid leukemia. Australian Leukemia Study GroupJ F Bishop, J P Matthews, G Young, et al.
Medical Mycology|January 30, 2017
Is a biomarker-based diagnostic strategy for invasive aspergillosis cost effective in high-risk haematology patients?N Macesic, C O Morrissey, D Liew, et al.
Blood|August 1, 1991
Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2E A Copelan, J C Biggs, J M Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1992
Radiation-free preparation for allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemiaE A Copelan, J C Biggs, B R Avalos, et al.
Transplantation Proceedings|March 27, 2001
Clinical relevance of the minor histocompatibility antigen HA-1 in allogeneic bone marrow transplantation between HLA identical siblingsB D Tait, R Maddison, J McCluskey, et al.
Bone Marrow Transplantation|July 30, 2013
Towards a global system of vigilance and surveillance in unrelated donors of haematopoietic progenitor cells for transplantationB E Shaw, J Chapman, M Fechter, et al.
Bone Marrow Transplantation|January 1, 1993
Effect of peripheral blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapyA Grigg, C G Begley, C A Juttner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1995
Adjuvant treatment of high-risk breast cancer using multicycle high-dose chemotherapy and filgrastim-mobilized peripheral blood progenitor cellsR L Basser, L B To, C G Begley, et al.
Bone Marrow Transplantation|July 1, 1994
Phase II study of autologous filgrastim (G-CSF)-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignanciesW P Sheridan, C G Begley, L B To, et al.
Internal Medicine Journal|December 9, 2014
Survey of antifungal prophylaxis and fungal diagnostic tests employed in malignant haematology and haemopoietic stem cell transplantation (HSCT) in Australia and New ZealandS J van Hal, N M Gilroy, C O Morrissey, et al.
Pageof 20